Fiabilidad de los predictores clínicos y de la biopsia de arteria ...
Fiabilidad de los predictores clínicos y de la biopsia de arteria ...
Fiabilidad de los predictores clínicos y de la biopsia de arteria ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Fiabilidad</strong> <strong>de</strong> <strong>los</strong> <strong>predictores</strong> <strong>clínicos</strong> y <strong>de</strong> <strong>la</strong> <strong>biopsia</strong> <strong>de</strong> <strong>arteria</strong> temporal en el diagnóstico <strong>de</strong> <strong>la</strong> arteritis <strong>de</strong> célu<strong>la</strong>s gigantes<br />
Joan Brunsó Casel<strong>la</strong>s<br />
152- Salvarani C, Hun<strong>de</strong>r GG. Giant cell arteritis with low erythrocyte<br />
sedimentation rate: Frequency of occurrence in a popu<strong>la</strong>tion-based study.<br />
Arthritis Care Res. 2001;45(2):140-5.<br />
153- Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia<br />
rheumatica and temporal arteritis: clinical and <strong>la</strong>boratory manifestations a<br />
onset of disease and at the time of diagnosis. Br J Rheumatol.<br />
1996;35:1161-8.<br />
154- Healey LA. Re<strong>la</strong>tion of giant cell arteritis to polymyalgia rheumatica.<br />
Baillieres Clin Rheumatol. 1991;5:371-8.<br />
155- Healey LA. Long-term follow-up of polymyalgia rheumatica: evi<strong>de</strong>nce for<br />
synovitis. Semin Arthritis Rheum. 1984;13(4):322-8.<br />
156- Weyand CM, Goronzy JJ. Giant Cell arteritis and polymyalgia rheumatica.<br />
Ann Intern Med. 2003;139:505-515.<br />
157- Martínez L, De Letona J, Carreño MC, Bilbao J, Román F, Pérez Maeztu R,<br />
et al..¿Es necesaria <strong>la</strong> <strong>biopsia</strong> <strong>de</strong> <strong>la</strong> <strong>arteria</strong> temporal? Estudio <strong>de</strong> 204<br />
<strong>biopsia</strong>s. Rev Clín Esp 1991; 189:325-7.<br />
158- González-Gay MA, García-Porrua C, Salvarini C, Hun<strong>de</strong>r GG. Diagnostic<br />
approach in a patient presenting with polymialgia. Clin Exp Rheumatol 1999;<br />
17:276-8.<br />
159- Kyle V, Hazleman BL. The clinical and <strong>la</strong>boratory course of polymyalgia<br />
rheumatica/giant cell arteritis after the first two months of treatment. Ann<br />
Rheum Dis. 1993;52:847-850.<br />
160- Rodríguez-Valver<strong>de</strong> V, Sarabia JM, González-Gay MA, et al. Risk factors<br />
and predictive mo<strong>de</strong>ls of giant cell arteritis in polymyalgia rheumatic. Am J<br />
Med 1994; 102:331.<br />
161- Hernan<strong>de</strong>z-Rodriguez J, Font C, Garcia-Martinez A, Espigol-Frigole G,<br />
Sanmarti R, Canete JD, Grau JM , Cid MC. Development of ischemic<br />
complications in patients with giant cell arteritis presenting with apparently<br />
iso<strong>la</strong>ted polymyalgia rheumatic: study of a series of 100 patients. Medicine<br />
2007; 86(4):233-241.<br />
162- Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM. Toll-like receptors in giant<br />
cell arteritis. Clin Immunol. 2005;115:38-46.<br />
163- Goronzy JJ, Weyand CM. Cytokines in giant-cell arteritis. Cleve Clin J Med.<br />
2002;69( 2):91-4.<br />
164- Weyand CM, Goronzy JJ. Pathogenic mechanisms in giant cell arteritis.<br />
Cleve Clin J Med. 2002;69:28-32.<br />
160
Change language